|
|
Key Issues Dialogue: von Willebrand Disease
Resources |
| The Women’s Hemostasis and Thrombosis Clinic at Duke University treats women who suffer from a bleeding disorder or who are on anticoagulation therapy and require management of menorrhagia; and women who have a bleeding or clotting disorder and are pregnant or desire a pregnancy. Founded in 2000, the clinic is part of the Duke Hemostasis & Thrombosis Center (HTC), which provides a multidisciplinary approach to the diagnosis and management of patients with a wide variety of hemostatic disorders and is a leader in basic research efforts, translational research, and related clinical trials. |
The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education, advocacy and research.
Established in 1948, the National Hemophilia Foundation is a nonprofit 501(c)3 organization with chapters throughout the country. Its programs and initiatives are made possible through the generosity of individuals, corporations and foundations as well as through a cooperative agreement with the Centers for Disease Control and Prevention (CDC).
For more information or for help, please call the organization’s information resource center at 800.42.HANDI, ext. 2 or go to www.hemophilia.org. |
ZLB Behring is one of the world’s leading pharmaceutical companies specializing in the manufacture of plasma products. Its comprehensive line of therapies include products for the treatment of hemophilia and other coagulation disorders, immunoglobulins for the prevention and treatment of immune disorders, treatments that inhibit the formation of blood clots, wound-healing agents used during major surgical procedures, and plasma expanders for the treatment of such conditions as shock, burns and circulatory disorders. Additionally, ZLB Behring operates one of the world’s largest plasma collection networks. ZLB Behring is committed to developing the next generation of therapeutic proteins to meet the demands of the evolving market.
At plants located in Bern, Switzerland; Marburg, Germany; and Kankakee, Ill., ZLB Behring manufactures therapies in accordance with international safety and quality standards. The products are distributed worldwide. ZLB Behring is a subsidiary of CSL Limited, a global pharmaceutical company based in Melbourne, Australia. |
| Back to Beginning
Previous: About the Participants
Return to Top |
|